Insulet Corporation · 11 hours ago
Sr Director, Type I Segment Enterprise Program Office (Hybrid/Flexible)
California, United States
Full-time
Hybrid
Director/Executive
$248K/yr - $373K/yr
12+ years expInsulet Corporation is an innovative medical device company dedicated to simplifying life for people with diabetes and other conditions. The Senior Director, Segment EPMO Leader is responsible for leading teams in the development and execution of new programs and technology implementation plans, ensuring alignment with corporate strategies and business objectives.
Health CareMedicalMedical Device
Responsibilities
Segment Team: Participates as a key team member and strategic partner within the segment leadership. Collaborates to align EPMO activities with strategic goals and initiates and leads cross-functional development programs and sustaining activities for all relevant products
Functional Teams: Participates across all functional area VP’s and Management staff in establishing overall product development program goals, scope, resources, and the plans for execution
Governance: Leads the governing and oversight of Insulet product development for the business segment through the newly formed segment PDT ensuring program status are clearly communicated and issues/risk are escalated and mitigated cross-functionally
EPMO: Provides leadership to the Enterprise Program Management Office to help ensure that Program Managers and cross-functional initiatives and efforts align with overall business strategies in order to achieve successful outcomes per established goals and objectives
Player/Coach: Assists in directing program teams responsible for the development of all approved programs and products with accountability for delivery success as defined through scope, schedule, and resources. Prepared to lead from above or from along-side program teams to ensure timely delivery and execution
People management: Hire, manage, and mentor staff for individual development and leadership in cross-functional product development programs
Specific Focus Area: Provides an unbiased, data-drive perspective of program status and risks to ensure Insulet is objectively managing product development
Performs additional duties as required
Qualification
Required
Bachelor's degree in related field
12+ years of related experience in product development within related field
Proven record of product development and implementation in electro-mechanic and/or software products
Experience with managing suppliers, external partners, and internal staff (at all levels)
Experience in the medical device industry with knowledge related to the FDA design control process
Preferred
Master's or PhD degree in related field
15+ years of related experience in product development within related field
Ability to influence and manage others both as direct reports, and matrix reports
Effective collaborator with strong IQ/EQ
Excellent verbal, written, and interpersonal communication skills
Ability to anticipate (“see around corners”) major challenges for hardware and software product development
Ability to organize and judge (triage) priorities
Ability to effectively handle multiple efforts simultaneously
Benefits
Medical, dental, and vision insurance
401(k) with company match
Paid time off (PTO)
And additional employee wellness programs
Company
Insulet Corporation
Insulet Corporation (NASDAQ: PODD), headquartered in Massachusetts, is an innovative medical device company dedicated to simplifying life for people with diabetes and other conditions through its Omnipod product platform.
1001-5000 employees
H1B Sponsorship
Insulet Corporation has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (58)
2024 (43)
2023 (19)
2022 (33)
2021 (41)
2020 (17)
Funding
Current Stage
Public CompanyTotal Funding
$629.5MKey Investors
DeerfieldOrbiMedAlta Partners
2025-03-18Post Ipo Debt· $450M
2009-03-16Post Ipo Debt· $60M
2007-05-15IPO
Leadership Team
Ashley McEvoy
President & Chief Executive Officer
Ana Maria Chadwick
Chief Financial Officer
Recent News
2025-12-20
2025-12-17
Company data provided by crunchbase